Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT)

Ophthalmology

Volumn 121, Issue 12, 2014, Pages 2423-2431

  Lee, Joo Yong ^a,b   Folgar, Francisco A ^a   Maguire, Maureen G ^c   Ying, Gui Shuang ^c   Toth, Cynthia A ^a   Martin, Daniel F ^d   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of Ulsan   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

AGE RELATED MACULAR DEGENERATION; ARTICLE; B SCAN; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; OUTER RETINAL TUBULATION; PREVALENCE; PRIORITY JOURNAL; RETINA DISEASE; RISK FACTOR; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; AGED; ANALYSIS OF VARIANCE; ANTAGONISTS AND INHIBITORS; CHOROIDAL NEOVASCULARIZATION; FEMALE; MACULAR DEGENERATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHOTORECEPTOR OUTER SEGMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINAL DISEASES;

AGED; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; PREVALENCE; PROSPECTIVE STUDIES; RANIBIZUMAB; RETINAL DISEASES; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84922257018     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.06.013     Document Type: Article

References (12)

1. A.H. Milam, and S.G. Jacobson Photoreceptor rosettes with blue cone opsin immunoreactivity in retinitis pigmentosa Ophthalmology 97 1990 1620 1631
2. S.A. Zweifel, M. Engelbert, and K. Laud Outer retinal tubulation: a novel optical coherence tomography finding Arch Ophthalmol 127 2009 1596 1602
3. W. Tulvatana, M. Adamian, E.L. Berson, and T.P. Dryja Photoreceptor rosettes in autosomal dominant retinitis pigmentosa with reduced penetrance Arch Ophthalmol 117 1999 399 402
4. A.A. Ellabban, M. Hangai, and K. Yamashiro Tomographic fundus features in pseudoxanthoma elasticum: comparison with neovascular age-related macular degeneration in Japanese patients Eye (Lond) 26 2012 1086 1094
5. J.J. Jung, and K.B. Freund Long-term follow-up of outer retinal tubulation documented by eye-tracked and en face spectral-domain optical coherence tomography [letter] Arch Ophthalmol 130 2012 1618 1619
6. P.I. Sergouniotis, A.E. Davidson, and E. Lenassi Retinal structure, function, and molecular pathologic features in gyrate atrophy Ophthalmology 119 2012 596 605
7. F.C. DeCroos, C.A. Toth, and S.S. Stinnett CATT Research Group. Optical coherence tomography grading reproducibility during the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 2012 2549 2557
8. CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
9. Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and G.S. Ying Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
10. F. Faria-Correia, R. Barros-Pereira, and L. Queiros-Mendanha Characterization of neovascular age-related macular degeneration patients with outer retinal tubulations Ophthalmologica 229 2013 147 151
11. G.S. Ying, J. Huang, and M.G. Maguire Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology 120 2013 122 129
12. Combination therapy a boon for AMD Phase IIb neovascular AMD study shows robust benefit for anti-PDGF/anti-VEGF therapy. Available at: http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/modernmedicine/modern-medicine-feature-articles/combination-therapy-boon-amd. Accessed June 9, 2014.